Annovis Bio's Buntanetap Shows Promise in Alzheimer's Treatment
October 9, 2025 — Annovis Bio's buntanetap shows reduced inflammatory biomarkers and improved neuronal health in Alzheimer's patients in Phase 2/3 study, suggesting potential disease-modifying effects.